Zobrazeno 1 - 10
of 99
pro vyhledávání: '"Wenzel, Catharina"'
Autor:
Fromm, Sabine, Bartsch, Rupert, Rudas, Margaretha, de Vries, Alexander, Wenzel, Catharina, Steger, Guenther G., Zielinski, Christoph C., Poetter, Richard, Dieckmann, Karin
Publikováno v:
In The Breast 2008 17(5):512-516
Autor:
Bartsch, Rupert, Fromm, Sabine, Rudas, Margaretha, Wenzel, Catharina, Harbauer, Stefanie, Roessler, Karl, Kitz, Klaus, Steger, Guenther G., Weitmann, Hajo-Dirk, Poetter, Richard, Zielinski, Christoph C., Dieckmann, Karin
Publikováno v:
In Radiotherapy and Oncology 2006 80(3):313-317
Autor:
Fazeny-Dörner, Barbara, Piribauer, Maria, Wenzel, Catharina, Fakhrai, Negar, Pirker, Christine, Berger, Walter, Sedivy, Roland, Rudas, Margarethe, Filipits, Martin, Okamoto, Ichi, Marosi, Christine
Publikováno v:
In Cancer Genetics and Cytogenetics 2003 146(2):161-166
Autor:
Locker Gottfried J, Altorjai Gabriela, Koestler Wolfgang, Sevelda Ursula, Pluschnig Ursula, Hussian Dagmar, Wenzel Catharina, Bartsch Rupert, Mader Robert, Zielinski Christoph C, Steger Guenther G
Publikováno v:
BMC Cancer, Vol 6, Iss 1, p 63 (2006)
Abstract Background Combining trastuzumab and chemotherapy is standard in her2/neu overexpressing advanced breast cancer. It is not established however, whether trastuzumab treatment should continue after the failure of one earlier combination. In th
Externí odkaz:
https://doaj.org/article/efdd5ff1172d4385b086646ed395fcfe
Autor:
Locker Gottfried J, Altorjai Gabriela, Sevelda Ursula, Hussian Dagmar, Pluschnig Ursula, Wenzel Catharina, Bartsch Rupert, Mader Robert, Zielinski Christoph C, Steger Guenther G
Publikováno v:
BMC Cancer, Vol 6, Iss 1, p 81 (2006)
Abstract Background At many centres tumour markers are used to detect disease recurrence and to monitor response to therapy in patients with advanced disease, although the real value of serial observation of marker levels remains disputed. In this st
Externí odkaz:
https://doaj.org/article/88ae174012c4490cb9da906821d20112
Autor:
Rudas, Margarethe, Schmidinger, Manuela, Wenzel, Catharina, Okamoto, Ichiro, Budinsky, Alexandra, Fazeny, Barbara, Marosi, Christine *
Publikováno v:
In Cancer Genetics and Cytogenetics 2000 121(2):190-193
Autor:
Bartsch, Rupert1, Wenzel, Catharina1, Zielinski, Christoph C.1, Steger, Guenther G.1 guenther.steger@meduniwien.ac.at
Publikováno v:
BioDrugs. 2007, Vol. 21 Issue 2, p69-77. 9p.
Autor:
Bartsch, Rupert1 rupert.bartsch@meduniwien.ac.at, Wenzel, Catharina1 catharina.wenzel@meduniwien.ac.at, Pluschnig, Ursula1 ursula.pluschnig@meduniwien.ac.at, Hussian, Dagmar1 dagmar.hussian@meduniwien.ac.at, Sevelda, Ursula1 ursula.sevelda@meduniwien.ac.at, Altorjai, Gabriela1 gabriela.altorjai@meduniwien.ac.at, Locker, Gottfried J1 gottfried.locker@meduniwien.ac.at, Mader, Robert1 robert.mader@meduniwien.ac.at, Zielinski, Christoph C1 christoph.zielinski@meduniwien.ac.at, Steger, Guenther G1 guenther.steger@meduniwien.ac.at
Publikováno v:
BMC Cancer. 2006, Vol. 6, p81-7. 7p. 2 Charts, 3 Graphs.
Autor:
Bartsch, Rupert1 rupert.bartsch@meduniwien.ac.at, Wenzel, Catharina1 catharina.wenzel@meduniwien.ac.at, Hussian, Dagmar1 dagmar.hussian@meduniwien.ac.at, Pluschnig, Ursula1 ursula.pluschnig@meduniwien.ac.at, Sevelda, Ursula1 ursula.sevelda@meduniwien.ac.at, Koestler, Wolfgang1 wolfgang.koestler@meduniwien.ac.at, Altorjai, Gabriela1 gabriela.altorjai@meduniwien.ac.at, Locker, Gottfried J.1 gottfried.locker@meduniwien.ac.at, Mader, Robert1 robert.mader@meduniwien.ac.at, Zielinski, Christoph C.1 christoph.zielinski@meduniwien.ac.at, Steger, Guenther G.1 guenther.steger@meduniwien.ac.at
Publikováno v:
BMC Cancer. 2006, Vol. 6, p63-6. 6p. 2 Charts, 1 Graph.
Publikováno v:
Biologics : Targets & Therapy
Trastuzumab is a monoclonal humanized antibody that has revolutionized the treatment of patients with Her2-positive breast cancer. Already well established in advanced stage disease, the substance was recently introduced in the adjuvant setting, redu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6571e9333d4b7d50bab6eb39614eb94d
http://europepmc.org/articles/PMC2721347
http://europepmc.org/articles/PMC2721347